Eledon Pharmaceuticals, Inc.
ELDN
$1.59
$0.117.43%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -79.79M | 14.64M | -19.05M | -36.18M | -21.67M |
| Total Depreciation and Amortization | 88.00K | 88.00K | 88.00K | 88.00K | 94.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.99M | -86.25M | -42.32M | -19.89M | -25.39M |
| Change in Net Operating Assets | 1.48M | 6.99M | 6.69M | 8.71M | 9.54M |
| Cash from Operations | -67.24M | -64.53M | -54.59M | -47.27M | -37.42M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -16.13M | -41.33M | -76.21M | -70.31M | -12.86M |
| Cash from Investing | -16.13M | -41.33M | -76.21M | -70.31M | -12.86M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 80.28M | 85.57M | 133.64M | 133.52M | 53.36M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 80.28M | 85.57M | 133.64M | 133.52M | 53.36M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.08M | -20.30M | 2.84M | 15.94M | 3.08M |